Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. V. Artamonova
Awareness and Treatment Specifics of Statin Therapy in Persons With Various Cardiovasular Risk: The Study Esse-Rf
Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular Medicine
Cardiology
The Prevalence of Anxiety and Depression in Different Regions of the Russian Federation and Its Association With Sociodemographic Factors (According to the Data of the ESSE-RF Study)
Terapevticheskii Arkhiv
Internal Medicine
Endocrinology
Metabolism
Diabetes
Prospective Study of Development of Cardiovascular Events in Relation With Cardiovascular Risk (Esse-Rf in Kemerovskaya Region)
Russian Journal of Cardiology
Cardiovascular Medicine
Cardiology
Long-Term Survival in Working-Age Patients After Cerebrovascular Accident
Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
Psychiatry
Mental Health
Neurology
The Association of Depression With C-Reactive Protein (The Data of Esse-Rf Epidemiological Study)
Rational Pharmacotherapy in Cardiology
Cardiovascular Medicine
Pharmacology
Cardiology
Related publications
Neuropsychiatric Outcomes After Stroke – Authors' Reply
The Lancet Neurology
Neurology
Maximising the Value of Research for Brain Health
The Lancet Neurology
Neurology
Cannabidiol in Patients With Treatment-Resistant Epilepsy
The Lancet Neurology
Neurology
WHO Takes Up the Baton on Dementia
The Lancet Neurology
Neurology
Learning About the Brain With Comics
The Lancet Neurology
Neurology
Functional (Psychogenic) Saccadic Oscillations and Oculogyric Crises – Authors' Reply
The Lancet Neurology
Neurology
Dream Weaver
The Lancet Neurology
Neurology
The Evolution of Universally Accessible Building Design
The Lancet Neurology
Neurology
Global, Regional, and National Burden of Meningitis, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016
The Lancet Neurology
Neurology
Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial
The Lancet Neurology
Neurology
